BioCentury | Jun 28, 2019
Product Development

How Array stayed alive long enough to grow up

...NASDAQ:ARRY) since 2000. InterMune Inc. collaborated with Array in 2002 to develop HCV drug Ganovo danoprevir. InterMune...
BioCentury | Jun 28, 2019
Company News

Management tracks: Gottlieb joins Pfizer board; plus Adaptimmune, Xencor, Arcus and more

...Polyphor's board on Aug. 31, was previously SVP, EU medical and global medical adviser at InterMune Inc....
BioCentury | Jul 13, 2018
Strategy

Roche’s partnering priority

...transactions for clinical-stage or marketed therapies. The pharma’s largest acquisition was its 2014 purchase of InterMune Inc....
BioCentury | Aug 18, 2017
Finance

IPF call options

...are just scratching the surface of their potential value, citing the $8.3 billion takeout of InterMune Inc....
BioCentury | May 15, 2017
Financial News

Genoa's series A brings in $62M

...InterMune Inc. , joined as an independent director. Genentech obtained Esbriet's rights via its acquisition of InterMune...
BioCentury | Feb 26, 2016
Company News

Management tracks

...developer Ascendis Pharma A/S (NASDAQ:ASND) named Jonathan Leff CMO. Leff was EVP of R&D at InterMune Inc....
BioCentury | Sep 30, 2015
Company News

Management tracks

...Corcept Therapeutics Inc. (NASDAQ:CORT) named Robert Fishman CMO. Fishman was SVP of clinical development at InterMune Inc....
BioCentury | Jul 22, 2015
Company News

Management tracks

...who is departing. Tripathi was VP of global regulatory affairs and clinical quality assurance at InterMune Inc....
BioCentury | Jul 7, 2015
Company News

Management tracks

...Morristown, N.J.) named Bill Bradford CMO. He was SVP of clinical science and biometrics at InterMune Inc....
BioCentury | Jun 19, 2015
Company News

Management tracks

...Nolan as CEO. He replaces John Carbona, who resigned in April. Nolan was CBO at InterMune Inc....
Items per page:
1 - 10 of 831
BioCentury | Jun 28, 2019
Product Development

How Array stayed alive long enough to grow up

...NASDAQ:ARRY) since 2000. InterMune Inc. collaborated with Array in 2002 to develop HCV drug Ganovo danoprevir. InterMune...
BioCentury | Jun 28, 2019
Company News

Management tracks: Gottlieb joins Pfizer board; plus Adaptimmune, Xencor, Arcus and more

...Polyphor's board on Aug. 31, was previously SVP, EU medical and global medical adviser at InterMune Inc....
BioCentury | Jul 13, 2018
Strategy

Roche’s partnering priority

...transactions for clinical-stage or marketed therapies. The pharma’s largest acquisition was its 2014 purchase of InterMune Inc....
BioCentury | Aug 18, 2017
Finance

IPF call options

...are just scratching the surface of their potential value, citing the $8.3 billion takeout of InterMune Inc....
BioCentury | May 15, 2017
Financial News

Genoa's series A brings in $62M

...InterMune Inc. , joined as an independent director. Genentech obtained Esbriet's rights via its acquisition of InterMune...
BioCentury | Feb 26, 2016
Company News

Management tracks

...developer Ascendis Pharma A/S (NASDAQ:ASND) named Jonathan Leff CMO. Leff was EVP of R&D at InterMune Inc....
BioCentury | Sep 30, 2015
Company News

Management tracks

...Corcept Therapeutics Inc. (NASDAQ:CORT) named Robert Fishman CMO. Fishman was SVP of clinical development at InterMune Inc....
BioCentury | Jul 22, 2015
Company News

Management tracks

...who is departing. Tripathi was VP of global regulatory affairs and clinical quality assurance at InterMune Inc....
BioCentury | Jul 7, 2015
Company News

Management tracks

...Morristown, N.J.) named Bill Bradford CMO. He was SVP of clinical science and biometrics at InterMune Inc....
BioCentury | Jun 19, 2015
Company News

Management tracks

...Nolan as CEO. He replaces John Carbona, who resigned in April. Nolan was CBO at InterMune Inc....
Items per page:
1 - 10 of 831